20/12/2025
We’d like to extend a special thank you to the participants and the NZCR team who contributed to the AZURE clinical trial. Because of your involvement, this study showed improved weight loss outcomes when the medication was used in combination with an existing treatment.
Find out more: rsobio.com/press-release/orsobio-announces-positive-topline-phase-1b-2a-clinical-data-for-its-oral-mitochondrial-protonophore-tlc-6740-in-combination-with-tirzepatide/
Could you play a part in advancing the next medical breakthrough? Register your interest today 👉nzcr.co.nz/register-with-new-zealand-clinical-research/